Lpl Financial LLC Chembio Diagnostics, Inc. Transaction History

Lpl Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.06 - $5.34 $43,023 - $111,525	-20,885 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$2.88 - $5.64 $12,113 - $23,721	-4,206 Reduced 16.76%	20,885 $62,000
Q1 2021 May 14, 2021	SELL	$3.4 - $7.97 $9,917 - $23,248	-2,917 Reduced 10.41%	25,091 $88,000
Q4 2020 Feb 12, 2021	BUY	$4.11 - $7.51 $2,055 - $3,755	500 Added 1.82%	28,008 $133,000
Q2 2020 Aug 13, 2020	SELL	$3.18 - $15.54 $48,746 - $238,212	-15,329 Reduced 35.78%	27,508 $89,000

Q1 2020 May 14, 2020	BUY	$2.36 - $5.6 $1,180 - $2,800	500 Added 1.18%	42,837 $219,000
Q4 2019 Feb 14, 2020	BUY	$3.94 - $5.76 $14,578 - $21,312	3,700 Added 9.58%	42,337 $193,000
Q3 2019 Nov 13, 2019	BUY	$4.84 - $7.25 $15,972 - $23,925	3,300 Added 9.34%	38,637 $236,000
Q2 2019 Aug 09, 2019	BUY	$5.56 - $7.85 $196,473 - $277,395	35,337 New	35,337 $215,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.